Evolution of the Average Target: Bastide Le Confort Médical

Evolution of the Target Price: Bastide Le Confort Médical

Changes in Analyst Recommendations: Bastide Le Confort Médical

332f986db739b7645fcb957484bad6.PTdspRJ3Wl6aFUU4bs04T7tWJUwq6gqqajQB4dU52m0.alMFkVg8Km31YzVpFooLLPYnVBx9nHuaPQdErJddjBtkYFjQdzo_DshQDA~99c9983b3b21507af07d864ad4ab44ed
05-18 Baader Europe maintains stance on Bastide le Confort Médical Zonebourse
05-15 Bastide Le Confort Medical: Guidance confirmed despite transitory regulatory headwinds in Q3 Alphavalue
03-19 Bastide Le Confort Medical: Sound H1 results, solid deleveraging, and reaffirmed FY guidance Alphavalue
03-19 Bastide results in line with guidance, says Oddo BHF Zonebourse
12-05 Bastide Le Confort Medical cuts EPS guidance Alphavalue
25-10-27 Bastide Le Confort Medical: In-line FY24/25 underlying results; smooth deleveraging Alphavalue
25-09-05 Bastide Le Confort Medical: In-line FY24/25 revenue; reconfirmed guidance Alphavalue
25-07-04 Bastide Le Confort Medical: Impact of strategic divestitures effective from next FY Alphavalue
25-06-06 Bastide: Oddo BHF still a buyer Zonebourse
25-05-16 Bastide Le Confort Medical: Reconfirmed guidance backed by compelling 9M turnover Alphavalue
25-03-20 Bastide Le Confort Medical: EPS cut (2024: -52.7%, 2025: -37.4%) Alphavalue
25-03-20 Bastide Le Confort Medical: Profitability gains neutralized by heavier financial expenses Alphavalue
25-03-20 Bastide: price target raised by Oddo BHF Zonebourse
25-03-14 Bastide Le Confort Medical: Debt reduction on the right trajectory Alphavalue
25-02-14 Bastide Le Confort Medical: Crystallizing a better revenue mix Alphavalue
24-11-27 Bastide: up sharply, a broker raises his recommendation Zonebourse
24-11-27 Bastide: Oddo BHF upgrades to 'outperform', raises target Zonebourse
24-11-15 Bastide Le Confort Medical: Better revenue mix; progress in portfolio review Alphavalue
24-10-28 Bastide Le Confort Medical: Margin build-up and debt reduction on a good trajectory Alphavalue
24-08-30 Bastide Le Confort Medical: Stronger qoq organic growth; guidance reiterated Alphavalue
24-05-15 Bastide Le Confort Medical: De facto maintained guidance; more disposals to propel debt reduction Alphavalue
24-04-09 Bastide Le Confort Medical: EPS upgrade (2023: 0.0%, 2024: +1.6%) Alphavalue
24-03-21 Bastide Le Confort Medical: The prioritised debt reduction awaits further visible progress Alphavalue
24-02-15 Bastide Le Confort Medical: Reiterated guidance and further progress on the in debt profile Alphavalue
23-11-19 BASTIDE LE CONFORT MEDICAL : Reconfirmed outlook and early progress in debt profile improvement Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +27.84%
-2.94%
+26.17%
+6.01%
- +42.84%
+237.46%
Average +56.23%
Weighted average by Cap. +2.09%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
24.25EUR
Average target price
31.00EUR
Spread / Average Target
+27.84%
High Price Target
31.00EUR
Spread / Highest target
+27.84%
Low Price Target
31.00EUR
Spread / Lowest Target
+27.84%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Yi Zhong
ODDO BHF
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
24.25EUR
Average target price
31.00EUR
Spread / Average Target
+27.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BLC Stock
  4. Consensus Bastide Le Confort Médical